Artificial Intelligence in Radiology and the Considerations for Regulation
Over a few short years, the presence of artificial intelligence in health care has grown quickly and as a result, considerations for AI regulation have become increasingly prevalent. Join this session to hear expert perspectives on the current and future state of AI governance in healthcare and radiology.
This on-demand webinar covers topics, such as:
-
Identify stakeholders in leading AI governance & Review processes for AI regulation
-
Address the importance of AI governance
-
Breakdown the current state of AI governance & Identify areas of strength and improvement
-
Explore the barriers to effective AI regulation
Dr. Lauren Nicola is the CEO of Triad Radiology Associates in Winston Salem NC, where she is subspecialized in breast imaging and pediatric radiology.
She is a national health policy expert, holding leadership positions in the American College of Radiology including serving as the chair of the Reimbursement Committee and as the ACR advisor to the Relative Value Scale Update Committee (RUC).
Dr. Angela Aristidou is an international award-winning academic (among other: Fulbright, UK Research Innovation FLF), currently at Stanford University with a prestigious CASBS award.
Professor Aristidou is an expert in how private tech companies, governments and public sector organisations, nonprofits and communities collaborate to innovate in healthcare.
Hortense Allison is Vice President and Head of Regulatory at Bayer Radiology Digital Solutions business. She held various positions with increasing responsibilities at different medical device companies with a focus on digital products.
She oversees business-critical regulatory strategy for AI/ML projects including the platform for deployment of radiology digital solutions and clinical applications.
-
Complete this form now to access the webinar
© 2023 Bayer
The descriptions, claims and visuals for all non-Bayer owned applications originate and are obtained from the application providers, or excerpted from publicly available information. Bayer is providing this content for your information, but does not own and control such content.
BAYER, the Bayer Cross and Calantic are trademarks owned by Bayer and/or registered in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners.
This is intended to provide information for healthcare professionals and other relevant decision makers in the US, European Union, United Kingdom and Switzerland. Not all offerings are available in all markets. For availability specific to your country please contact your local Bayer representative. These materials are exclusively for professional use.
The product Calantic Viewer has CE marking (CE2797). Complies with medical device legislation. Consult the operating instructions of a product for its intended use, characteristics and performance, contraindications, name of the manufacturer or its authorized representative and other essential information. The operating instructions of the product Calantic Viewer can be found on https://www.radiology.bayer.com/manuals
You are encouraged to report adverse events; reporting information can be found on https://www.bayer.com/en/pharma/report-side-effect
Any individuals depicted in this website are actors and not actual health care providers or patients. All patient data is fictitious. Images are an artistic representation for illustrative purposes only.
Last update: September 2023